Clinical Trial Update: YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer [NA]

View source ↗

Summary

This entry reports a clinical trial evaluating YSQTG combined with immuno-chemotherapy for extensive-stage small cell lung cancer. The study is currently enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• YSQTG

Snippet

Sponsor: LI FENG | Conditions: Extensive-stage Small Cell Lung Cancer (SCLC) | NA | Status: ENROLLING_BY_INVITATION